CAPLACIZUMAB

UNII:	2R27AB6766
Formula:
Preferred Substance Name:	CAPLACIZUMAB

915810-67-2
ALX-0081
CABLIVI
CAPLACIZUMAB [INN]
CAPLACIZUMAB [JAN]
CAPLACIZUMAB [MI]
CAPLACIZUMAB [USAN]
CAPLACIZUMAB [WHO-DD]
CAPLACIZUMAB YHDP [WHO-DD]
CAPLACIZUMAB-YHDP
CAPLACIZUMAB-YHDP [PURPLE BOOK CDER]
IMMUNOGLOBULIN VH-LINKER-VH FRAGMENT, ANTI-(HOMO SAPIENS VWF (VON WILLEBRAND FACTOR) A1 DOMAIN), HUMANIZED MONOCLONAL ANTIBODY VH-LINKER-VH CHAIN (1-259) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*04 (82.5%) -(IGHD)-IGHJ4*01 L123>Q (123) (8.8.21) (1-128)) -TRIALANYL LINKER (129-131)-(HUMANIZED VH (HOMO SAPIENS IGHV3-23*04 (82.5%) -(IGHD)-IGHJ4*01 L123>Q(254) (8.8.21) (132-259).
IMMUNOGLOBULIN, ANTI-(HUMAN VON WILLEBRAND'S BLOOD-COAGULATION FACTOR VIII DOMAIN A1) (HUMAN-LAMA GLAMA DIMERIC HEAVY CHAIN FRAGMENT PMP12A2H1)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CAPLACIZUMAB

Synonyms and Mappings

Resources